Paracelsus Medical Private University (PMU)

Institute of Pharmacology and Toxicology
Research Projects

Back

Pioneering Pendrin Proteomics - PPP

#Salzburg
#Pharmacology and Toxicology

Functional and molecular characterization of the pendrin (SLC26A4) mutation p.L117 F, Erasmus+ student mobility traineeship, Martyna Rajch, University of Poznan, Poland

#Salzburg
#Pharmacology and Toxicology

Erasmus+ Staff Mobility for Training Elisabeth Mooslechner, Dublin City University

#Salzburg
#Pharmacology and Toxicology

Erasmus+ Staff Mobility for Training Raffaella Liuni, FELASA Berlin

#Salzburg
#Pharmacology and Toxicology

Novel genetic determinants contribute to hearing loss in a central European cohort with enlarged vestibular aqueduct

#Salzburg
#Pharmacology and Toxicology

Role of Renal Intercalated Cells in Alkali Sensing

#Salzburg
#Pharmacology and Toxicology

Role of Renal Intercalated Cells in Alkali Sensing (sense-pH)

#Salzburg
#Pharmacology and Toxicology

Real-world cisplatin-ototoxicity in adult patients with bronchial carcinoma or head and neck squamous cell carcinoma: a pilot study and registry

#Salzburg
#Nuremberg
#Pharmacology and Toxicology
#Institut für Klinische Pharmakologie Nbg

PMU-RDF-004-Dossena Research Development Fund

#Salzburg
#Pharmacology and Toxicology

Research on the molecular features of pendrin protein variants associated with non-syndromic hearing loss and pendred syndrome, Marek Sklenar, Comenius University, Faculty of Natural Sciences, Bratislava, Slovakia, Erasmus+ Program, Student Mobility for Traineeships

#Salzburg
#Pharmacology and Toxicology

Molecular mechanisms in hearing loss, Houssein Nasser, Università degli Studi di Pavia (I), Pharmacy, Erasmus+ Program, Student Mobility for Traineeships

#Salzburg
#Pharmacology and Toxicology

Identification of novel therapeutic targets in Pendred syndrome/DFNB4

#Salzburg
#Pharmacology and Toxicology

Identification of novel therapeutic targets in Pendred syndrome/DFNB4

#Salzburg
#Pharmacology and Toxicology

Identification of senescence markers in cochlea sections from young vs. old mice, Erasmus staff mobility for training Emanuele Bernardinelli, Bioacustic Research Laboratory of the University of Padua (Italy)

#Salzburg
#Pharmacology and Toxicology

Determination of the functional activity, cellular expression levels and subcellular localization of the variant p.L117F of mouse pendrin (Slc26a4), Gianluca Mantegna Erasmus stipend

#Salzburg
#Pharmacology and Toxicology

Physiopathological role of the K+-ATP channel in an in vitro neuronal model of Parkinson`s disease, PhD program Sara Spinelli in Applied Biology and Experimental Medicine

#Salzburg
#Pharmacology and Toxicology

A new mouse model of pendred syndrome and non-syndromic deafness DFNB4

#Salzburg
#Pharmacology and Toxicology

Completion of “Determination of the functional activity, cellular expression levels and subcellular localization of the variant p.L117F of mouse pendrin (Slc26a4)”. / Erasmus internship Arnoldas Matulevicius

#Salzburg
#Pharmacology and Toxicology

Deciphering signaling pathways for LPAR-dependent gene transcription and tumor t

#Salzburg
#Pharmacology and Toxicology

Determination of the functional activity, cellular expression levels and subcellular localization of the variant p.L117F of mouse pendrin (Slc26a4) / Erasamus internship Arnoldas Matulevicius

#Salzburg
#Pharmacology and Toxicology
Back Research Research Projects Teaching Research and diagnostic services Publications Team & Contact
Back to Overview
Paracelsus Medical Private University (PMU) Research & Innovation Institutes, Centers and Programs
Research Projects